tranScrip is a specialist pharmaceutical consultancy that helps biopharmaceutical companies transform great science into valuable medicines. Our senior multidisciplinary experts work as an extension of your team, combining medical, clinical, regulatory and commercial expertise to design and deliver integrated development programmes across the entire product lifecycle. From product strategy and early development through to registration, commercialisation and lifecycle management, we provide the strategic insight and hands-on delivery needed to reduce risk, protect value and accelerate progress. By combining deep therapeutic expertise with practical execution, we help you navigate complexity, make confident decisions and bring innovative medicines to patients faster.
| Website | http://www.transcrip-group.com |
| Revenue | $7 million |
| Employees | 86 (53 on RocketReach) |
| Founded | 2008 |
| Address | 100 Berkshire Place, Wokingham, England RG41 5RD, GB |
| Industry | Business Consulting and Services |
| Keywords | Pharmaceutical Consultancy, Strategic Expertise, Product Lifecycle Management, Pharma Consulting, Drug Development, Biopharmaceutical Consulting, Pharmaceutical Strategy, Regulatory Affairs, Product Strategy, Pharmaceutical Operations, Life Sciences Consulting, Clinical Trials, Development Operations, Healthcare Consulting, Drug Product Development, Regulatory Strategy, Clinical Development, Medical Affairs, Pharmacovigilance |
| Competitors | Research Pharmaceutical Services, IQVIA, PPD, Syneos Health, Charles River Laboratories, Medpace, Covance, Celerion, Clinipace Worldwide, Pharmerit +33 more (view full list) |
Looking for a particular tranScrip employee's phone or email?
The tranScrip annual revenue was $7 million in 2026.
Karen Real is the Founder, SVP Business Development of tranScrip.
53 people are employed at tranScrip.
tranScrip is based in Wokingham, England.